SCHEMBL6208824

SCHEMBL6208824

O=C(c1ccc(Cl)cc1)C1CCN(S(=O)(=O)c2cccs2)CC1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.67
ALDH1A1 P00352 3/20 0.64
RAB9A P51151 3/20 0.62
MAPK1 P28482 1/20 0.62
NPC1 O15118 2/20 0.60
HPGD P15428 1/20 0.60
MAPT P10636 3/20 0.60
LMNA P02545 3/20 0.60
TP53 P04637 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
PKM P14618 3/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
CCR1 P32246 1/20 0.57
EPHX2 P34913 1/20 0.57
GAA P10253 1/20 0.56
RECQL P46063 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5472424 0.81 SMN1; SMN2 (0.64) POLBALDH1A1RAB9ANPC1HPGD
SCHEMBL5472420 0.81 SMN1; SMN2 (0.64) POLBALDH1A1RAB9ANPC1HPGD
SCHEMBL3916331 0.80 POLB (1.00) POLBALDH1A1RAB9AMAPK1NPC1
SCHEMBL2042088 0.79 POLB (0.77) POLBALDH1A1RAB9ANPC1HPGD
SCHEMBL6209685 0.77 ALDH1A1 (0.70) ALDH1A1MAPTLMNATP53L3MBTL1
SCHEMBL7315799 0.76 L3MBTL1 (0.76) MAPTLMNATP53L3MBTL1MEN1
SCHEMBL7315808 0.76 L3MBTL1 (0.76) MAPTLMNATP53L3MBTL1MEN1
SCHEMBL7076195 0.75 MGLL (0.59) ALDH1A1MAPTLMNATP53L3MBTL1
SCHEMBL5481469 0.74 MEN1 (0.63) POLBALDH1A1RAB9AMAPK1L3MBTL1
SCHEMBL5481466 0.74 MEN1 (0.63) POLBALDH1A1RAB9AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256159-A1 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors ASTRAZENECA AB (SE) 2005-11-17 US disclosed
EP-1556349-A1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES AND THEIR USE AS 11-BETAHSD1 INHIBITORS Astrazeneca AB (SE) 2005-07-27 EP disclosed
WO-2004033427-A1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES AND THEIR USE AS 11-BETAHSD1 INHIBITORS ASTRAZENECA AB (SE) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256159-A1 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors HSD11B1, HSD3B1, P4HA1 POLB 1926/4885ALDH1A1 14/4885RAB9A 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.